Please login to the form below

Not currently logged in
Email:
Password:

European biotech

This page shows the latest European biotech news and features for those working in and with pharma, biotech and healthcare.

Mega-mergers dominate as buoyant markets lift biopharma

Mega-mergers dominate as buoyant markets lift biopharma

The biotech has also managed to increase its share price since its launch, a feat not frequently achieved in the sector. ... a new surge in confidence in European biotech.

Latest news

More from news
Approximately 21 fully matching, plus 34 partially matching documents found.

Latest Intelligence

  • Building European biotech firms to rival those of the US Building European biotech firms to rival those of the US

    Germany is European biotech’s sleeping giant. “Germany is Europe’s great untapped player in biotech,” said Richard. ... produced far fewer biotech companies than you would expect, it’s definitely the place to watch.”.

  • European biotech: a new generation of leaders emerges European biotech: a new generation of leaders emerges

    biotechs’. The growing role of specialist venture capital. One of the key ingredients in these and other recent European biotech success stories is long-term backing from investors. ... European biotech is benefiting from this new support to translate

  • Building Europe’s next breakthrough biotechs Building Europe’s next breakthrough biotechs

    Cambridge's new Biomedical Campus is home to specialist NHS trusts, AstraZeneca's new HQ and biotech firms. ... How can the UK life science ecosystem produce even more biotech start-ups, and propel them to long-term success?

  • 25 Women Leaders in UK Healthcare 25 Women Leaders in UK Healthcare

    It’s long been recognised that one of the biggest factors holding back UK and European biotech success has been a paucity of leaders, and that’s why efforts are being ... As well as overseeing the European communications group for Syneos Health, she

  • European venture funding for the life science sector European venture funding for the life science sector

    Capital markets infrastructure is a barrier. European biotech companies continue to find it hard to raise public money in Europe. ... Pockets of success on Euronext mask the fact that leading European venture groups primarily look to the Nasdaq, at least

More from intelligence
Approximately 2 fully matching, plus 7 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Pegasus

Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching...

Latest intelligence

Language barriers: Obesity has become a loaded word
...
Spotlight interview: 15 minutes on digital in medical communications
Gemma Allen, Head of Digital Communications, OPEN Health takes 15 minutes to answer some key questions on digital in medical communications...
Generating data on long-term outcomes with gene and other advanced therapies
Gene therapy and advanced cell-based therapies offer patients hope and the potential to make them ‘chronically well’....

Infographics